Municipal, state, direct city, sacred forest area market supervision:
The price disclosure scheme for health institutions in hubei province (preliminary) has been considered for adoption by the office of the director-general for market supervision of the province and is being circulated to you for implementation。
Hubei market supervisory authority
7 november 2022
Hubei health institutions price disclosure scheme
(piloted)
In order to regulate the publication of prices in health-care institutions, to maintain the market price order for medical services and to protect the legitimate rights and interests of health-care providers and operators involved, this approach is based on laws, regulations, regulations and rules such as the price law of the people's republic of china, the consumer protection law of the people's republic of china, the regulation on administrative penalties for price offences of the people's republic of china, the regulation on the regulation of price infractions and the provisions on the prohibition of price fraud。
Article 2. The content, modalities and requirements for the publication of prices in the various health-care institutions within the province's administrative area, as well as their supervision and management, shall apply to this scheme。

Article 3 health-care institutions shall be guided by the principles of openness, fairness and integrity, and shall regulate, accurate, complete and transparent price information for all medical services provided, medicines and medical consumables (hereinafter referred to as medical consumables) for which exceptions are included. Changes in information should be updated in a timely manner。
For the purposes of this approach, goods and services that should be priced are those that are subject to market-regulated, government-directed prices。
Article 4 - health-care institutions may not use false or misleading forms of price publicity to deceive or mislead clients. No additional charges may be charged over and above the published price. Services may not be imposed and charged for, but not paid for, or charged for。
Article 5 health-care institutions shall establish a price publicity system, which shall be accessible through electronic touch screens, electronic displays, public displays, billboards, price sheets, self-help search devices, etc., in visible locations on their own portals, fee windows, billing sections, etc., and shall provide price query services to clients of medical services, proactively informing them of the means of searching and facilitating access。
Article 6. The cost of medical services is disclosed in the following terms: health service project code, project name, project content, exclusion, unit of measure, project description, price, etc。
If public health institutions announce the price of health services and apply the government-directed price, it shall include the price of guidance from the government and the price of implementation by the health-care institutions; if a market-regulated price is applied, it shall be indicated; and the matter of services that are freely chosen by the clients of health services shall be specified。
Care services should be publicized or communicated to a hierarchical care system, including information on the level of care, the content of care, the rate of fees, etc。
Medical ambulance services should inform the ambulance, visitation and pre-hospital first aid rates in advance。

Article 7. Medical orders and records of medical treatment shall be fully and accurately communicated, in accordance with the relevant medical technical norms, to the use of medicines, consumables and medical diagnostic services, and shall not be used for improper purposes, such as increasing fees and obtaining the relevant returns, to deceive, induce or compel the subject of medical care to repeat the examination, overuse the medication and overuse the medical treatment. Commercial bribery through extensive prescriptions, excessive medical care and other means is prohibited。
Article 8 drug price publicity includes information on generic names, trade names, formulation types, specifications, unit of measure, sales prices, manufacturers, etc. Of medicines。
Article 9 publicity of the prices of medical consumables includes information on the name of the certificate of registration, the name of the product, the specification, the model, the unit of measure, the price of the sale, the manufacturer, etc。
Article 10 provides that, where a medical service can be broken down into multiple projects and charged separately, each project and the fee rate shall be clearly identified, the commingling of bid prices or bundled charges shall be prohibited, and if the fee cannot be deciphered, the project shall not be decomposed to raise the fee or duplicate the fee。
Article 11: health-care institutions shall provide the clients of health services with a list of the cost of medical services, medicines, medical consumables, etc. The cost list includes:
(i) the home (emergency) and hospital treatment shall provide the clients of the medical service with a written or electronic list of the costs of the home (emergency) consultation, a list of the daily costs of hospitalization and a list of the total costs of hospitalization. The list includes the following: code of medical services, project name, medicine, name of medical consumables, unit of measure, price (including government-directed prices, implementation price or market pricing criteria), quantity, amount, etc. The daily cost list data for hospitalization shall be retained for at least three months after the discharge of the medical client and for at least six months after the discharge of the medical client. Health institutions should facilitate the search, printing and downloading of lists of clients。
(ii) when performing a medical operation, the medical institution shall, in writing, inform the subject of the medical service or his or her signatory of the procedure (including, but not limited to, the path to the proposed treatment, the name of the operation, the name of the drug, and information on the place of production of the medical material involved in the treatment, the manufacturer, the quantity used, the place of use, etc。
(iii) the introduction of sickness-based medical services, with only a statement of the amount to be provided, including the rate for the disease, the cost of an ultra-ordinary standard bed, the availability of additional medical supplies, the name of the cost of medical services for obstetrical needs, the project, the unit of measure, the quantity, the amount, etc。

Article 12. Health-care institutions should publicize the “12315” market regulating complaints and reporting hotline, the “12345” government service people's hotline and its own price advice, complaint telephones in the main fee and service windows。
If citizens, legal persons or other organizations find that health-care institutions do not publicize this approach, they can file a complaint with the market regulator。
Article 13 - monitoring and inspection by the market regulator of the price of health-care institutions, in accordance with the law, shall be carried out in cooperation with the health-care institutions and shall be subject to inquiry and investigation, as appropriate, to provide relevant information。
Article 14 states that, if the health-care institutions fail to publicize the provisions of this act, they shall be subject to inspection by the supervisory authorities of the county or higher market, in accordance with laws, regulations, regulations, etc. Of the price law of the people's republic of china, the consumer protection law of the people's republic of china, the regulation on administrative penalties for price infractions of the law of the people's republic of china on countering unfair competition, the regulation on the regulation of clear pricing and prohibition of price fraud。
Article 15: in carrying out their monitoring and inspection, the staff of the market supervisory authority shall be held accountable for the abuse of their functions, negligence and favouritism, in violation of the relevant laws and regulations。
Article 16, this approach is interpreted by the hubei provincial market supervision authority。
Article 17 this scheme is in effect from 1 december 2022。




